ALGS Aligos Therapeutics, Inc.

NASDAQ
$6.21

Aligos Therapeutics, Inc. (ALGS) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

The three months from September 5

From September, on average
+7.11%
21 matching years
Any three months
-2.82%
1,415 starting points
Difference
+9.9 pts
better than usual

Both lines start at zero on day 0, so the vertical gap reads directly as percentage points better or worse than a random three months. A seasonal line sitting on top of the baseline is a real answer: it says the calendar tells you nothing here. Price history from October 2020 to September 2026.

Between earnings releases

The same study run on the earnings cycle rather than the calendar: the average move from one report to the next, broken out by fiscal quarter, with the announcement gap and the run-up separated out.

Sign in or subscribe to see it